Loading...
Loading...
SurModics, Inc.
SRDX, a leading provider of surface modification and
in vitro diagnostic technologies to the healthcare industries, today announced
that effective August 27, 2012, Mr. Jeffrey Smith has resigned from SurModics'
Board of Directors.
“Upon joining SurModics' Board of Directors in January of 2011, my goal was to
work collaboratively with my fellow directors and the management team to
create and enhance value for all shareholders,” commented Jeffrey Smith.
“These objectives have been successfully accomplished as demonstrated by
SurModics' strong financial results. As a result, the Company is
well-positioned to continue to drive profitable core organic revenue growth."
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: NewsManagement
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in